All Relations between dat and dopamine
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| E Martignoni, G Bono, F Blandini, E Sinforiani, P Merlo, G Napp. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. Journal of neural transmission. Parkinson's disease and dementia section. vol 3. issue 1. 1991-08-14. PMID:1712206. | the cerebrospinal fluid (csf) levels of norepinephrine (ne), epinephrine (e), dopamine (da), 3-methoxy-4-hydroxyphenylglycol (mhpg), 5-hydroxyindoleacetic acid (5-hiaa), and homovanillic acid (hva) were studied in 14 patients suffering from dementia of alzheimer type (dat) and in 14 controls. | 1991-08-14 | 2023-08-11 | Not clear |
| D C Costa, N P Verhoeff, I D Cullum, P J Ell, G M Syed, J Barrett, E Palazidou, B Toone, E Van Royen, M Bobeldij. In vivo characterisation of 3-iodo-6-methoxybenzamide 123I in humans. European journal of nuclear medicine. vol 16. issue 11. 1990-11-13. PMID:2209650. | 3-iodo-6-methoxybenzamide (123i-ibzm), a new dopamine d2 receptor ligand, was used in conjunction with sme 810 brain tomography to study six subjects (one normal volunteer, four schizophrenics and one dat patient). | 1990-11-13 | 2023-08-11 | human |
| S Lal, N P Nair, J X Thavundayil, V Tawar, Y Tesfaye, D Dastoor, S Gauthier, H Guyd. Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type. Neurobiology of aging. vol 10. issue 3. 1989-08-17. PMID:2664540. | the growth hormone (gh) response to the dopamine (da) receptor agonist, apomorphine hcl (apo) (0.5 mg sc) was studied in young and elderly normal subjects as well as in patients with dementia of the alzheimer type (dat) and controls matched for age, gender and quetelet index. | 1989-08-17 | 2023-08-11 | human |